|Name||Hilton San Francisco Union Square|
|Anschrift||333 O’Farrell Street|
|Stadt||94102 San Franciso, United States|
|Name||Cassidy HamiltonEBD Group, supported by Biotechnology Industry Organization (BIO)|
The investor conference that drives the future of drug development.
Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The 2018 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its eleventh year, Biotech Showcase 2019 is expected to feature presentations by over 400 public and private companies and attract more than 3,600 attendees, including 900 investors. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends.
The demand for innovation in all areas of human health is the impetus behind Digital Medicine & Medtech Showcase, a focus event taking place during Biotech Showcase at Parc 55 in San Francisco. The event brings together key stakeholders at the convergence of traditional therapeutics, digital tools, combination products, companion diagnostics, precision medicine, AI and other technical advances to explore funding opportunities, partnerships and collaboration.
Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.
Demy-Colton Life Science Advisors and EBD Group, Inc.